AgNOR clusters as a parameter of cell kinetics in chronic lymphocytic leukaemia
- PMID: 16696103
- PMCID: PMC408087
- DOI: 10.1136/mp.49.6.m357
AgNOR clusters as a parameter of cell kinetics in chronic lymphocytic leukaemia
Abstract
Aims-To study correlations between the pattern of silver stained nucleolar organiser regions (AgNORs) in chronic lymphocytic leukaemia (CLL) and parameters of tumour kinetics. To investigate whether quantitation of the AgNOR pattern can be used to discriminate between patients with stable and progressive disease.Methods-Peripheral blood smears from 48 patients with CLL, classified as having either stable or progressive disease (Rai stage III or IV; bulky lymph nodes or massive splenomegaly; or peripheral lymphocytes >100 x 10(9)/1), were studied. For each patient, total tumour mass (TTM) and for patients undergoing a period of observation without treatment, the TTM duplication time (DT) and the lymphocyte doubling time (LDT) were calculated.Results-Four cell types could be distinguished according to their AgNOR pattern: (1) cells with a single cluster; (2) cells with a single compact nucleolus; (3) cells with two compact nucleoli; and (4) cells with several scattered dots. The percentage of cells with clusters was the AgNOR parameter which correlated best with TTM and LDT. Correlations were also seen between the proportion of cells with clusters and age and haemoglobin concentration. A significant correlation with DT could be detected only when age was kept constant. Linear discriminant analysis revealed that the percentage of cells with clusters was the most important prognostic factor. This alone classified 94% of the patients correctly (jackknive procedure) as either stable or progressive CLL.Conclusions-The percentage of circulating lymphocytes with clusters of AgNORs can be used as a parameter of tumour kinetics in CLL and helps to discriminate between patients with stable and progressive disease. For practical purposes, a value of more than 13% of cells with clusters is suggestive of progressive disease.
Similar articles
-
Changes in AgNOR configurations during the evolution and treatment of chronic lymphocytic leukemia.Hematol Cell Ther. 1999 Nov;41(5):205-10. doi: 10.1007/s00282-999-0205-5. Hematol Cell Ther. 1999. PMID: 10651120
-
Nucleolus organizer regions (AgNORs) and total tumor mass are independent prognostic parameters for treatment-free period in chronic lymphocytic leukemia.Int J Cancer. 2000 Sep 20;89(5):440-3. doi: 10.1002/1097-0215(20000920)89:5<440::aid-ijc7>3.0.co;2-u. Int J Cancer. 2000. PMID: 11008206
-
Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.Neoplasma. 2003;50(6):408-15. Neoplasma. 2003. PMID: 14689061
-
AgNOR staining and quantification.Micron. 2000 Apr;31(2):127-31. doi: 10.1016/s0968-4328(99)00069-4. Micron. 2000. PMID: 10588058 Review.
-
[Silver-stained Nucleolar Organizer Regions (AgNOR)].Pathologica. 2001 Apr;93(2):99-105. Pathologica. 2001. PMID: 11428299 Review. Italian.
Cited by
-
Methods for analysing AgNORs.J Clin Pathol. 1999 Jul;52(7):550. doi: 10.1136/jcp.52.7.550a. J Clin Pathol. 1999. PMID: 10605415 Free PMC article. No abstract available.
-
Apoptosis and expression of argyrophilic nucleolus organizer regions in epithelial neoplasms of the larynx.Braz J Otorhinolaryngol. 2015 Mar-Apr;81(2):158-66. doi: 10.1016/j.bjorl.2014.12.003. Epub 2014 Dec 27. Braz J Otorhinolaryngol. 2015. PMID: 25617064 Free PMC article.
-
Texture analysis of the epidermis based on fast Fourier transformation in Sjögren-Larsson syndrome.Anal Quant Cytol Histol. 2006 Aug;28(4):219-27. Anal Quant Cytol Histol. 2006. PMID: 16927642 Free PMC article.
References
LinkOut - more resources
Full Text Sources